<?xml version="1.0" encoding="UTF-8" ?><xml><records><record><database name="My EndNote Library.enl" path="/Users/james/Documents/My EndNote Library.enl">My EndNote Library.enl</database><source-app name="EndNote" version="18.2">EndNote</source-app><rec-number>2</rec-number><foreign-keys><key app="EN" db-id="av2daspe00da2re0d5dvwfa709xdr29ffzrv">2</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alkhabbaz, M. A.</style></author><author><style face="normal" font="default" size="100%">Bollini, P.</style></author><author><style face="normal" font="default" size="100%">Foo, G. S.</style></author><author><style face="normal" font="default" size="100%">Sievers, C.</style></author><author><style face="normal" font="default" size="100%">Jones, C. W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">School of Chemical &amp; Bimolecular Engineering, Georgia Institute of Technology , 311 Ferst Drive, Atlanta, Georgia 30332, United States.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Important roles of enthalpic and entropic contributions to CO2 capture from simulated flue gas and ambient air using mesoporous silica grafted amines</style></title><secondary-title><style face="normal" font="default" size="100%">J Am Chem Soc</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Am Chem Soc</style></full-title></periodical><pages><style face="normal" font="default" size="100%">13170-3</style></pages><volume><style face="normal" font="default" size="100%">136</style></volume><number><style face="normal" font="default" size="100%">38</style></number><edition><style face="normal" font="default" size="100%">2014/09/13</style></edition><dates><year><style face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style face="normal" font="default" size="100%">Sep 24</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1520-5126 (Electronic)&#xD;0002-7863 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">25215519</style></accession-num><abstract><style face="normal" font="default" size="100%">The measurement of isosteric heats of adsorption of silica supported amine materials in the low pressure range (0-0.1 bar) is critical for understanding the interactions between CO2 and amine sites at low coverage and hence to the development of efficient amine adsorbents for CO2 capture from flue gas and ambient air. Heats of adsorption for an array of silica-supported amine materials are experimentally measured at low coverage using a Calvet calorimeter equipped with a customized dosing manifold. In a series of 3-aminopropyl-functionalized silica materials, higher amine densities resulted in higher isosteric heats of adsorption, clearly showing that the density/proximity of amine sites can influence the amine efficiency of adsorbents. In a series of materials with fixed amine loading but different amine types, strongly basic primary and secondary amine materials are shown to have essentially identical heats of adsorption near 90 kJ/mol. However, the adsorption uptakes vary substantially as a function of CO2 partial pressure for different primary and secondary amines, demonstrating that entropic contributions to adsorption may play a key role in adsorption at secondary amine sites, making adsorption at these sites less efficient at the low coverages that are important to the direct capture of CO2 from ambient air. Thus, while primary amines are confirmed to be the most effective amine types for CO2 capture from ambient air, this is not due to enhanced enthalpic contributions associated with primary amines over secondary amines, but may be due to unfavorable entropic factors associated with organization of the second alkyl chain on the secondary amine during CO2 adsorption. Given this hypothesis, favorable entropic factors may be the main reason primary amine based adsorbents are more effective under air capture conditions.</style></abstract><notes><style face="normal" font="default" size="100%">Alkhabbaz, Mustafa A&#xD;Bollini, Praveen&#xD;Foo, Guo Shiou&#xD;Sievers, Carsten&#xD;Jones, Christopher W&#xD;eng&#xD;J Am Chem Soc. 2014 Sep 24;136(38):13170-3. doi: 10.1021/ja507655x. Epub 2014 Sep 12.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/25215519</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1021/ja507655x</style></electronic-resource-num></record><record><database name="My EndNote Library.enl" path="/Users/james/Documents/My EndNote Library.enl">My EndNote Library.enl</database><source-app name="EndNote" version="18.2">EndNote</source-app><rec-number>1</rec-number><foreign-keys><key app="EN" db-id="av2daspe00da2re0d5dvwfa709xdr29ffzrv">1</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Aung, T.</style></author><author><style face="normal" font="default" size="100%">Ozaki, M.</style></author><author><style face="normal" font="default" size="100%">Mizoguchi, T.</style></author><author><style face="normal" font="default" size="100%">Allingham, R. R.</style></author><author><style face="normal" font="default" size="100%">Li, Z.</style></author><author><style face="normal" font="default" size="100%">Haripriya, A.</style></author><author><style face="normal" font="default" size="100%">Nakano, S.</style></author><author><style face="normal" font="default" size="100%">Uebe, S.</style></author><author><style face="normal" font="default" size="100%">Harder, J. M.</style></author><author><style face="normal" font="default" size="100%">Chan, A. S.</style></author><author><style face="normal" font="default" size="100%">Lee, M. C.</style></author><author><style face="normal" font="default" size="100%">Burdon, K. P.</style></author><author><style face="normal" font="default" size="100%">Astakhov, Y. S.</style></author><author><style face="normal" font="default" size="100%">Abu-Amero, K. K.</style></author><author><style face="normal" font="default" size="100%">Zenteno, J. C.</style></author><author><style face="normal" font="default" size="100%">Nilgun, Y.</style></author><author><style face="normal" font="default" size="100%">Zarnowski, T.</style></author><author><style face="normal" font="default" size="100%">Pakravan, M.</style></author><author><style face="normal" font="default" size="100%">Safieh, L. A.</style></author><author><style face="normal" font="default" size="100%">Jia, L.</style></author><author><style face="normal" font="default" size="100%">Wang, Y. X.</style></author><author><style face="normal" font="default" size="100%">Williams, S.</style></author><author><style face="normal" font="default" size="100%">Paoli, D.</style></author><author><style face="normal" font="default" size="100%">Schlottmann, P. G.</style></author><author><style face="normal" font="default" size="100%">Huang, L.</style></author><author><style face="normal" font="default" size="100%">Sim, K. S.</style></author><author><style face="normal" font="default" size="100%">Foo, J. N.</style></author><author><style face="normal" font="default" size="100%">Nakano, M.</style></author><author><style face="normal" font="default" size="100%">Ikeda, Y.</style></author><author><style face="normal" font="default" size="100%">Kumar, R. S.</style></author><author><style face="normal" font="default" size="100%">Ueno, M.</style></author><author><style face="normal" font="default" size="100%">Manabe, S.</style></author><author><style face="normal" font="default" size="100%">Hayashi, K.</style></author><author><style face="normal" font="default" size="100%">Kazama, S.</style></author><author><style face="normal" font="default" size="100%">Ideta, R.</style></author><author><style face="normal" font="default" size="100%">Mori, Y.</style></author><author><style face="normal" font="default" size="100%">Miyata, K.</style></author><author><style face="normal" font="default" size="100%">Sugiyama, K.</style></author><author><style face="normal" font="default" size="100%">Higashide, T.</style></author><author><style face="normal" font="default" size="100%">Chihara, E.</style></author><author><style face="normal" font="default" size="100%">Inoue, K.</style></author><author><style face="normal" font="default" size="100%">Ishiko, S.</style></author><author><style face="normal" font="default" size="100%">Yoshida, A.</style></author><author><style face="normal" font="default" size="100%">Yanagi, M.</style></author><author><style face="normal" font="default" size="100%">Kiuchi, Y.</style></author><author><style face="normal" font="default" size="100%">Aihara, M.</style></author><author><style face="normal" font="default" size="100%">Ohashi, T.</style></author><author><style face="normal" font="default" size="100%">Sakurai, T.</style></author><author><style face="normal" font="default" size="100%">Sugimoto, T.</style></author><author><style face="normal" font="default" size="100%">Chuman, H.</style></author><author><style face="normal" font="default" size="100%">Matsuda, F.</style></author><author><style face="normal" font="default" size="100%">Yamashiro, K.</style></author><author><style face="normal" font="default" size="100%">Gotoh, N.</style></author><author><style face="normal" font="default" size="100%">Miyake, M.</style></author><author><style face="normal" font="default" size="100%">Astakhov, S. Y.</style></author><author><style face="normal" font="default" size="100%">Osman, E. A.</style></author><author><style face="normal" font="default" size="100%">Al-Obeidan, S. A.</style></author><author><style face="normal" font="default" size="100%">Owaidhah, O.</style></author><author><style face="normal" font="default" size="100%">Al-Jasim, L.</style></author><author><style face="normal" font="default" size="100%">Al Shahwan, S.</style></author><author><style face="normal" font="default" size="100%">Fogarty, R. A.</style></author><author><style face="normal" font="default" size="100%">Leo, P.</style></author><author><style face="normal" font="default" size="100%">Yetkin, Y.</style></author><author><style face="normal" font="default" size="100%">Oguz, C.</style></author><author><style face="normal" font="default" size="100%">Kanavi, M. R.</style></author><author><style face="normal" font="default" size="100%">Beni, A. N.</style></author><author><style face="normal" font="default" size="100%">Yazdani, S.</style></author><author><style face="normal" font="default" size="100%">Akopov, E. L.</style></author><author><style face="normal" font="default" size="100%">Toh, K. Y.</style></author><author><style face="normal" font="default" size="100%">Howell, G. R.</style></author><author><style face="normal" font="default" size="100%">Orr, A. C.</style></author><author><style face="normal" font="default" size="100%">Goh, Y.</style></author><author><style face="normal" font="default" size="100%">Meah, W. Y.</style></author><author><style face="normal" font="default" size="100%">Peh, S. Q.</style></author><author><style face="normal" font="default" size="100%">Kosior-Jarecka, E.</style></author><author><style face="normal" font="default" size="100%">Lukasik, U.</style></author><author><style face="normal" font="default" size="100%">Krumbiegel, M.</style></author><author><style face="normal" font="default" size="100%">Vithana, E. N.</style></author><author><style face="normal" font="default" size="100%">Wong, T. Y.</style></author><author><style face="normal" font="default" size="100%">Liu, Y.</style></author><author><style face="normal" font="default" size="100%">Koch, A. E.</style></author><author><style face="normal" font="default" size="100%">Challa, P.</style></author><author><style face="normal" font="default" size="100%">Rautenbach, R. M.</style></author><author><style face="normal" font="default" size="100%">Mackey, D. A.</style></author><author><style face="normal" font="default" size="100%">Hewitt, A. W.</style></author><author><style face="normal" font="default" size="100%">Mitchell, P.</style></author><author><style face="normal" font="default" size="100%">Wang, J. J.</style></author><author><style face="normal" font="default" size="100%">Ziskind, A.</style></author><author><style face="normal" font="default" size="100%">Carmichael, T.</style></author><author><style face="normal" font="default" size="100%">Ramakrishnan, R.</style></author><author><style face="normal" font="default" size="100%">Narendran, K.</style></author><author><style face="normal" font="default" size="100%">Venkatesh, R.</style></author><author><style face="normal" font="default" size="100%">Vijayan, S.</style></author><author><style face="normal" font="default" size="100%">Zhao, P.</style></author><author><style face="normal" font="default" size="100%">Chen, X.</style></author><author><style face="normal" font="default" size="100%">Guadarrama-Vallejo, D.</style></author><author><style face="normal" font="default" size="100%">Cheng, C. Y.</style></author><author><style face="normal" font="default" size="100%">Perera, S. A.</style></author><author><style face="normal" font="default" size="100%">Husain, R.</style></author><author><style face="normal" font="default" size="100%">Ho, S. L.</style></author><author><style face="normal" font="default" size="100%">Welge-Luessen, U. C.</style></author><author><style face="normal" font="default" size="100%">Mardin, C.</style></author><author><style face="normal" font="default" size="100%">Schloetzer-Schrehardt, U.</style></author><author><style face="normal" font="default" size="100%">Hillmer, A. M.</style></author><author><style face="normal" font="default" size="100%">Herms, S.</style></author><author><style face="normal" font="default" size="100%">Moebus, S.</style></author><author><style face="normal" font="default" size="100%">Nothen, M. M.</style></author><author><style face="normal" font="default" size="100%">Weisschuh, N.</style></author><author><style face="normal" font="default" size="100%">Shetty, R.</style></author><author><style face="normal" font="default" size="100%">Ghosh, A.</style></author><author><style face="normal" font="default" size="100%">Teo, Y. Y.</style></author><author><style face="normal" font="default" size="100%">Brown, M. A.</style></author><author><style face="normal" font="default" size="100%">Lischinsky, I.</style></author><author><style face="normal" font="default" size="100%">Blue Mountains Eye Study, Gwas Team</style></author><author><style face="normal" font="default" size="100%">Wellcome Trust Case Control, Consortium</style></author><author><style face="normal" font="default" size="100%">Crowston, J. G.</style></author><author><style face="normal" font="default" size="100%">Coote, M.</style></author><author><style face="normal" font="default" size="100%">Zhao, B.</style></author><author><style face="normal" font="default" size="100%">Sang, J.</style></author><author><style face="normal" font="default" size="100%">Zhang, N.</style></author><author><style face="normal" font="default" size="100%">You, Q.</style></author><author><style face="normal" font="default" size="100%">Vysochinskaya, V.</style></author><author><style face="normal" font="default" size="100%">Founti, P.</style></author><author><style face="normal" font="default" size="100%">Chatzikyriakidou, A.</style></author><author><style face="normal" font="default" size="100%">Lambropoulos, A.</style></author><author><style face="normal" font="default" size="100%">Anastasopoulos, E.</style></author><author><style face="normal" font="default" size="100%">Coleman, A. L.</style></author><author><style face="normal" font="default" size="100%">Wilson, M. R.</style></author><author><style face="normal" font="default" size="100%">Rhee, D. J.</style></author><author><style face="normal" font="default" size="100%">Kang, J. H.</style></author><author><style face="normal" font="default" size="100%">May-Bolchakova, I.</style></author><author><style face="normal" font="default" size="100%">Heegaard, S.</style></author><author><style face="normal" font="default" size="100%">Mori, K.</style></author><author><style face="normal" font="default" size="100%">Alward, W. L.</style></author><author><style face="normal" font="default" size="100%">Jonas, J. B.</style></author><author><style face="normal" font="default" size="100%">Xu, L.</style></author><author><style face="normal" font="default" size="100%">Liebmann, J. M.</style></author><author><style face="normal" font="default" size="100%">Chowbay, B.</style></author><author><style face="normal" font="default" size="100%">Schaeffeler, E.</style></author><author><style face="normal" font="default" size="100%">Schwab, M.</style></author><author><style face="normal" font="default" size="100%">Lerner, F.</style></author><author><style face="normal" font="default" size="100%">Wang, N.</style></author><author><style face="normal" font="default" size="100%">Yang, Z.</style></author><author><style face="normal" font="default" size="100%">Frezzotti, P.</style></author><author><style face="normal" font="default" size="100%">Kinoshita, S.</style></author><author><style face="normal" font="default" size="100%">Fingert, J. H.</style></author><author><style face="normal" font="default" size="100%">Inatani, M.</style></author><author><style face="normal" font="default" size="100%">Tashiro, K.</style></author><author><style face="normal" font="default" size="100%">Reis, A.</style></author><author><style face="normal" font="default" size="100%">Edward, D. P.</style></author><author><style face="normal" font="default" size="100%">Pasquale, L. R.</style></author><author><style face="normal" font="default" size="100%">Kubota, T.</style></author><author><style face="normal" font="default" size="100%">Wiggs, J. L.</style></author><author><style face="normal" font="default" size="100%">Pasutto, F.</style></author><author><style face="normal" font="default" size="100%">Topouzis, F.</style></author><author><style face="normal" font="default" size="100%">Dubina, M.</style></author><author><style face="normal" font="default" size="100%">Craig, J. E.</style></author><author><style face="normal" font="default" size="100%">Yoshimura, N.</style></author><author><style face="normal" font="default" size="100%">Sundaresan, P.</style></author><author><style face="normal" font="default" size="100%">John, S. W.</style></author><author><style face="normal" font="default" size="100%">Ritch, R.</style></author><author><style face="normal" font="default" size="100%">Hauser, M. A.</style></author><author><style face="normal" font="default" size="100%">Khor, C. C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">1] Singapore Eye Research Institute, Singapore. [2] Singapore National Eye Center, Singapore. [3] Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. [4] Division of Human Genetics, Genome Institute of Singapore, Singapore. [5] Duke University-National University of Singapore Graduate Medical School, Singapore.&#xD;1] Ozaki Eye Hospital, Hyuga, Japan. [2] Hayashi Eye Hospital, Fukuoka, Japan.&#xD;Mizoguchi Eye Hospital, Sasebo, Japan.&#xD;Department of Ophthalmology, Duke University Eye Center, Durham, North Carolina, USA.&#xD;Division of Human Genetics, Genome Institute of Singapore, Singapore.&#xD;Intraocular Lens and Cataract Clinic, Aravind Eye Hospital, Madurai, India.&#xD;Department of Ophthalmology, Oita University Faculty of Medicine, Oita, Japan.&#xD;Institute of Human Genetics, Friedrich Alexander Universitat Erlangen-Nurnberg, Erlangen-Nurnberg, Germany.&#xD;Howard Hughes Medical Institute, Jackson Laboratory, Bar Harbor, Maine, USA.&#xD;1] Singapore Eye Research Institute, Singapore. [2] Singapore National Eye Center, Singapore.&#xD;Singapore Eye Research Institute, Singapore.&#xD;1] Department of Ophthalmology, Flinders University, Adelaide, South Australia, Australia. [2] Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.&#xD;Department of Ophthalmology, First Pavlov State Medical University of St. Petersburg, St. Petersburg, Russia.&#xD;1] Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia. [2] Department of Ophthalmology, College of Medicine, University of Florida, Jacksonville, Florida, USA.&#xD;1] Department of Genetics, Institute of Ophthalmology Conde de Valenciana, Mexico City, Mexico. [2] Department of Biochemistry, Faculty of Medicine, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico.&#xD;Department of Ophthalmology, Eskisehir Osmangazi University, Meselik, Turkey.&#xD;Department of Diagnostics and Microsurgery of Glaucoma, Medical University, Lublin, Poland.&#xD;Department of Ophthalmology, Ophthalmic Research Center, Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.&#xD;King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.&#xD;Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing Tongren Eye Centre, Beijing Tongren Hospital, Capital Medical University, Beijing, China.&#xD;Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital University of Medical Science, Beijing, China.&#xD;Division of Ophthalmology, Department of Neurosciences, University of the Witwatersrand, Johannesburg, South Africa.&#xD;Department of Ophthalmology, Monfalcone Hospital, Gorizia, Italy.&#xD;Organizacion Medica de Investigacion, Buenos Aires, Argentina.&#xD;1] Sichuan Provincial Key Laboratory for Human Disease Gene Study, Hospital of the University of Electronic Science and Technology of China and Sichuan Provincial People&apos;s Hospital, Chengdu, China. [2] School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. [3] Sichuan Translational Medicine Hospital, Chinese Academy of Sciences, Chengdu, China.&#xD;Department of Genomic Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan.&#xD;Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.&#xD;Glaucoma Services, Narayana Nethralaya Eye Hospital, Bangalore, India.&#xD;Hayashi Eye Hospital, Fukuoka, Japan.&#xD;Shinjo Eye Clinic, Miyazaki, Japan.&#xD;Ideta Eye Hospital, Kumamoto, Japan.&#xD;Miyata Eye Hospital, Miyazaki, Japan.&#xD;1] Miyata Eye Hospital, Miyazaki, Japan. [2] Department of Ophthalmology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.&#xD;Department of Ophthalmology and Visual Science, Kanazawa University Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.&#xD;Sensho-kai Eye Institute, Kyoto, Japan.&#xD;Inouye Eye Hospital, Tokyo, Japan.&#xD;Department of Medicine and Engineering Combined Research Institute, Asahikawa Medical University, Asahikawa, Japan.&#xD;Department of Ophthalmology, Asahikawa Medical University, Asahikawa, Japan.&#xD;Department of Ophthalmology and Visual Science, Hiroshima University, Hiroshima, Japan.&#xD;Yotsuya Shirato Eye Clinic, Tokyo, Japan.&#xD;Ohashi Eye Center, Sapporo, Japan.&#xD;Tane Memorial Eye Hospital, Osaka, Japan.&#xD;Department of Ophthalmology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.&#xD;Center for Genomic Medicine/INSERM U852, Kyoto University Graduate School of Medicine, Kyoto, Japan.&#xD;Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.&#xD;1] Center for Genomic Medicine/INSERM U852, Kyoto University Graduate School of Medicine, Kyoto, Japan. [2] Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.&#xD;Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.&#xD;Department of Ophthalmology, Flinders University, Adelaide, South Australia, Australia.&#xD;University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia.&#xD;Department of Ophthalmology and Visual Sciences, Dalhousie University, Halifax, Nova Scotia, Canada.&#xD;1] Singapore Eye Research Institute, Singapore. [2] Singapore National Eye Center, Singapore. [3] Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.&#xD;1] Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA. [2] Department of Cellular Biology and Anatomy, Georgia Regents University, Augusta, Georgia, USA.&#xD;Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.&#xD;Division of Ophthalmology, Faculty of Medicine and Health Sciences, University of Stellenbosch, Cape Town, South Africa.&#xD;Centre for Ophthalmology and Visual Science, Lions Eye Institute, University of Western Australia, Perth, Western Australia, Australia.&#xD;1] Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia. [2] Centre for Eye Research Australia (CERA), University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia.&#xD;Centre for Vision Research, Department of Ophthalmology and Westmead Millennium Institute, University of Sydney, Sydney, New South Wales, Australia.&#xD;Department of Genetics, Aravind Medical Research Foundation, Madurai, India.&#xD;Department of Ophthalmology, Xin Hua Hospital affiliated to Shanghai Jiao Tong University, School of Medicine, Shanghai, China.&#xD;Department of Ophthalmology, First Affiliated Hospital of Xinjiang Medical University, Urumchi, Xinjiang Uygur Autonomous Region, China.&#xD;1] Singapore Eye Research Institute, Singapore. [2] Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.&#xD;National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore.&#xD;Department of Ophthalmology, Friedrich Alexander Universitat Erlangen-Nurnberg, Erlangen-Nurnberg, Germany.&#xD;Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore.&#xD;1] Institute of Human Genetics, University of Bonn, Bonn, Germany. [2] Department of Genomics, Life &amp;Brain Center, University of Bonn, Bonn, Germany. [3] Division of Medical Genetics, University Hospital, Basel, Switzerland. [4] Human Genetics Research Group, Department of Biomedicine, University of Basel, Basel, Switzerland.&#xD;Institute for Medical Informatics, Biometry and Epidemiology, University Hospital of Essen, University Duisburg-Essen, Essen, Germany.&#xD;1] Institute of Human Genetics, University of Bonn, Bonn, Germany. [2] Department of Genomics, Life &amp;Brain Center, University of Bonn, Bonn, Germany.&#xD;Institute for Ophthalmic Research, Department of Ophthalmology, Tubingen, Germany.&#xD;1] Singapore Eye Research Institute, Singapore. [2] Genes, Repair and Regeneration in Ophthalmic Workstation Research Laboratory, Narayana Nethralaya Foundation, Bangalore, India.&#xD;1] Department of Ophthalmology, Duke University Eye Center, Durham, North Carolina, USA. [2] Saw Swee Hock School of Public Health, National University of Singapore, Singapore.&#xD;Centro Oftalmologico Lischinsky, Tucuman, Argentina.&#xD;1] Centre for Eye Research Australia (CERA), University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia. [2] Department of Ophthalmology, University of Melbourne, Melbourne, Victoria, Australia.&#xD;St. Petersburg Academic University, St. Petersburg, Russia.&#xD;Department of Ophthalmology, Faculty of Medicine, Aristotle University of Thessaloniki, American Hellenic Educational Progressive Association Hospital, Thessaloniki, Greece.&#xD;Department of Biology and Genetics, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.&#xD;Center for Community Outreach and Policy, Stein Eye Institute, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California, USA.&#xD;Wayne State University, Detroit, Michigan, USA.&#xD;Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.&#xD;Channing Division of Network Medicine, Brigham and Women&apos;s Hospital, Boston, Massachusetts, USA.&#xD;Department of Ophthalmology, Military Hospital Begin, Paris, France.&#xD;1] Eye Pathology Institute, Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark. [2] Department of Ophthalmology, Glostrup University Hospital, Glostrup, Denmark.&#xD;1] Stephen A. Wynn Institute for Vision Research, University of Iowa, Iowa City, Iowa, USA. [2] Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.&#xD;Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht Karls University Heidelberg, Heidelberg, Germany.&#xD;New York University School of Medicine, Manhattan Eye, Ear and Throat Hospital, New York, New York, USA.&#xD;Division of Medical Sciences, Humphrey Oei Institute of Cancer Research, National Cancer Centre of Singapore, Singapore.&#xD;Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.&#xD;1] Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany. [2] Department of Clinical Pharmacology, University Hospital, Tubingen, Germany. [3] German Cancer Consortium (DKTK), German Cancer Research Center, Heidelberg, Germany.&#xD;Fundacion para el Estudio del Glaucoma, Buenos Aires, Argentina.&#xD;Department of Surgery, Section of Ophthalmology, University of Siena, Siena, Italy.&#xD;Department of Ophthalmology, Faculty of Medical Science, University of Fukui, Fukui, Japan.&#xD;1] King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia. [2] Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.&#xD;1] Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA. [2] Channing Division of Network Medicine, Brigham and Women&apos;s Hospital, Boston, Massachusetts, USA.&#xD;1] Department of Ophthalmology, First Pavlov State Medical University of St. Petersburg, St. Petersburg, Russia. [2] St. Petersburg Academic University, St. Petersburg, Russia.&#xD;Einhorn Clinical Research Center, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, USA.&#xD;1] Department of Ophthalmology, Duke University Eye Center, Durham, North Carolina, USA. [2] Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.&#xD;1] Singapore Eye Research Institute, Singapore. [2] Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. [3] Division of Human Genetics, Genome Institute of Singapore, Singapore.</style></auth-address><titles><title><style face="normal" font="default" size="100%">A common variant mapping to CACNA1A is associated with susceptibility to exfoliation syndrome</style></title><secondary-title><style face="normal" font="default" size="100%">Nat Genet</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Nat Genet</style></full-title></periodical><pages><style face="normal" font="default" size="100%">387-92</style></pages><volume><style face="normal" font="default" size="100%">47</style></volume><number><style face="normal" font="default" size="100%">4</style></number><edition><style face="normal" font="default" size="100%">2015/02/24</style></edition><keywords><keyword><style face="normal" font="default" size="100%">Animals</style></keyword><keyword><style face="normal" font="default" size="100%">Asian Continental Ancestry Group/genetics/statistics &amp; numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">Calcium Channels/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Case-Control Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Chromosome Mapping</style></keyword><keyword><style face="normal" font="default" size="100%">Exfoliation Syndrome/epidemiology/*genetics</style></keyword><keyword><style face="normal" font="default" size="100%">Genetic Predisposition to Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Genome-Wide Association Study</style></keyword><keyword><style face="normal" font="default" size="100%">Glaucoma, Open-Angle/epidemiology/genetics</style></keyword><keyword><style face="normal" font="default" size="100%">HEK293 Cells</style></keyword><keyword><style face="normal" font="default" size="100%">HeLa Cells</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Japan/epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">MCF-7 Cells</style></keyword><keyword><style face="normal" font="default" size="100%">Mice</style></keyword><keyword><style face="normal" font="default" size="100%">Mice, Inbred C57BL</style></keyword><keyword><style face="normal" font="default" size="100%">*Polymorphism, Single Nucleotide</style></keyword><keyword><style face="normal" font="default" size="100%">Tumor Cells, Cultured</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style face="normal" font="default" size="100%">Apr</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1546-1718 (Electronic)&#xD;1061-4036 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">25706626</style></accession-num><abstract><style face="normal" font="default" size="100%">Exfoliation syndrome (XFS) is the most common recognizable cause of open-angle glaucoma worldwide. To better understand the etiology of XFS, we conducted a genome-wide association study (GWAS) of 1,484 cases and 1,188 controls from Japan and followed up the most significant findings in a further 6,901 cases and 20,727 controls from 17 countries across 6 continents. We discovered a genome-wide significant association between a new locus (CACNA1A rs4926244) and increased susceptibility to XFS (odds ratio (OR) = 1.16, P = 3.36 x 10(-11)). Although we also confirmed overwhelming association at the LOXL1 locus, the key SNP marker (LOXL1 rs4886776) demonstrated allelic reversal depending on the ancestry group (Japanese: OR(A allele) = 9.87, P = 2.13 x 10(-217); non-Japanese: OR(A allele) = 0.49, P = 2.35 x 10(-31)). Our findings represent the first genetic locus outside of LOXL1 surpassing genome-wide significance for XFS and provide insight into the biology and pathogenesis of the disease.</style></abstract><notes><style face="normal" font="default" size="100%">Aung, Tin&#xD;Ozaki, Mineo&#xD;Mizoguchi, Takanori&#xD;Allingham, R Rand&#xD;Li, Zheng&#xD;Haripriya, Aravind&#xD;Nakano, Satoko&#xD;Uebe, Steffen&#xD;Harder, Jeffrey M&#xD;Chan, Anita S Y&#xD;Lee, Mei Chin&#xD;Burdon, Kathryn P&#xD;Astakhov, Yury S&#xD;Abu-Amero, Khaled K&#xD;Zenteno, Juan C&#xD;Nilgun, Yildirim&#xD;Zarnowski, Tomasz&#xD;Pakravan, Mohammad&#xD;Safieh, Leen Abu&#xD;Jia, Liyun&#xD;Wang, Ya Xing&#xD;Williams, Susan&#xD;Paoli, Daniela&#xD;Schlottmann, Patricio G&#xD;Huang, Lulin&#xD;Sim, Kar Seng&#xD;Foo, Jia Nee&#xD;Nakano, Masakazu&#xD;Ikeda, Yoko&#xD;Kumar, Rajesh S&#xD;Ueno, Morio&#xD;Manabe, Shin-ichi&#xD;Hayashi, Ken&#xD;Kazama, Shigeyasu&#xD;Ideta, Ryuichi&#xD;Mori, Yosai&#xD;Miyata, Kazunori&#xD;Sugiyama, Kazuhisa&#xD;Higashide, Tomomi&#xD;Chihara, Etsuo&#xD;Inoue, Kenji&#xD;Ishiko, Satoshi&#xD;Yoshida, Akitoshi&#xD;Yanagi, Masahide&#xD;Kiuchi, Yoshiaki&#xD;Aihara, Makoto&#xD;Ohashi, Tsutomu&#xD;Sakurai, Toshiya&#xD;Sugimoto, Takako&#xD;Chuman, Hideki&#xD;Matsuda, Fumihiko&#xD;Yamashiro, Kenji&#xD;Gotoh, Norimoto&#xD;Miyake, Masahiro&#xD;Astakhov, Sergei Y&#xD;Osman, Essam A&#xD;Al-Obeidan, Saleh A&#xD;Owaidhah, Ohoud&#xD;Al-Jasim, Leyla&#xD;Al Shahwan, Sami&#xD;Fogarty, Rhys A&#xD;Leo, Paul&#xD;Yetkin, Yaz&#xD;Oguz, Cilingir&#xD;Kanavi, Mozhgan Rezaei&#xD;Beni, Afsaneh Nederi&#xD;Yazdani, Shahin&#xD;Akopov, Evgeny L&#xD;Toh, Kai-Yee&#xD;Howell, Gareth R&#xD;Orr, Andrew C&#xD;Goh, Yufen&#xD;Meah, Wee Yang&#xD;Peh, Su Qin&#xD;Kosior-Jarecka, Ewa&#xD;Lukasik, Urszula&#xD;Krumbiegel, Mandy&#xD;Vithana, Eranga N&#xD;Wong, Tien Yin&#xD;Liu, Yutao&#xD;Koch, Allison E Ashley&#xD;Challa, Pratap&#xD;Rautenbach, Robyn M&#xD;Mackey, David A&#xD;Hewitt, Alex W&#xD;Mitchell, Paul&#xD;Wang, Jie Jin&#xD;Ziskind, Ari&#xD;Carmichael, Trevor&#xD;Ramakrishnan, Rangappa&#xD;Narendran, Kalpana&#xD;Venkatesh, Rangaraj&#xD;Vijayan, Saravanan&#xD;Zhao, Peiquan&#xD;Chen, Xueyi&#xD;Guadarrama-Vallejo, Dalia&#xD;Cheng, Ching Yu&#xD;Perera, Shamira A&#xD;Husain, Rahat&#xD;Ho, Su-Ling&#xD;Welge-Luessen, Ulrich-Christoph&#xD;Mardin, Christian&#xD;Schloetzer-Schrehardt, Ursula&#xD;Hillmer, Axel M&#xD;Herms, Stefan&#xD;Moebus, Susanne&#xD;Nothen, Markus M&#xD;Weisschuh, Nicole&#xD;Shetty, Rohit&#xD;Ghosh, Arkasubhra&#xD;Teo, Yik Ying&#xD;Brown, Matthew A&#xD;Lischinsky, Ignacio&#xD;Crowston, Jonathan G&#xD;Coote, Michael&#xD;Zhao, Bowen&#xD;Sang, Jinghong&#xD;Zhang, Nihong&#xD;You, Qisheng&#xD;Vysochinskaya, Vera&#xD;Founti, Panayiota&#xD;Chatzikyriakidou, Anthoula&#xD;Lambropoulos, Alexandros&#xD;Anastasopoulos, Eleftherios&#xD;Coleman, Anne L&#xD;Wilson, M Roy&#xD;Rhee, Douglas J&#xD;Kang, Jae Hee&#xD;May-Bolchakova, Inna&#xD;Heegaard, Steffen&#xD;Mori, Kazuhiko&#xD;Alward, Wallace L M&#xD;Jonas, Jost B&#xD;Xu, Liang&#xD;Liebmann, Jeffrey M&#xD;Chowbay, Balram&#xD;Schaeffeler, Elke&#xD;Schwab, Matthias&#xD;Lerner, Fabian&#xD;Wang, Ningli&#xD;Yang, Zhenglin&#xD;Frezzotti, Paolo&#xD;Kinoshita, Shigeru&#xD;Fingert, John H&#xD;Inatani, Masaru&#xD;Tashiro, Kei&#xD;Reis, Andre&#xD;Edward, Deepak P&#xD;Pasquale, Louis R&#xD;Kubota, Toshiaki&#xD;Wiggs, Janey L&#xD;Pasutto, Francesca&#xD;Topouzis, Fotis&#xD;Dubina, Michael&#xD;Craig, Jamie E&#xD;Yoshimura, Nagahisa&#xD;Sundaresan, Periasamy&#xD;John, Simon W M&#xD;Ritch, Robert&#xD;Hauser, Michael A&#xD;Khor, Chiea-Chuen&#xD;eng&#xD;R01 EY011721/EY/NEI NIH HHS/&#xD;R29 EY011721/EY/NEI NIH HHS/&#xD;EY018825/EY/NEI NIH HHS/&#xD;085475/08/Z/Wellcome Trust/United Kingdom&#xD;R01 EY018825/EY/NEI NIH HHS/&#xD;EY023512/EY/NEI NIH HHS/&#xD;R01 EY020928/EY/NEI NIH HHS/&#xD;Howard Hughes Medical Institute/&#xD;085475/B/08/Z/Wellcome Trust/United Kingdom&#xD;P30 EY014104/EY/NEI NIH HHS/&#xD;EY11721/EY/NEI NIH HHS/&#xD;R01 EY023512/EY/NEI NIH HHS/&#xD;R01 EY013882/EY/NEI NIH HHS/&#xD;Research Support, N.I.H., Extramural&#xD;Research Support, Non-U.S. Gov&apos;t&#xD;Nat Genet. 2015 Apr;47(4):387-92. doi: 10.1038/ng.3226. Epub 2015 Feb 23.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/25706626</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">PMC4605818</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/ng.3226</style></electronic-resource-num></record><record><database name="My EndNote Library.enl" path="/Users/james/Documents/My EndNote Library.enl">My EndNote Library.enl</database><source-app name="EndNote" version="18.2">EndNote</source-app><rec-number>5</rec-number><foreign-keys><key app="EN" db-id="av2daspe00da2re0d5dvwfa709xdr29ffzrv">5</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Demessence, A.</style></author><author><style face="normal" font="default" size="100%">D&apos;Alessandro, D. M.</style></author><author><style face="normal" font="default" size="100%">Foo, M. L.</style></author><author><style face="normal" font="default" size="100%">Long, J. R.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Chemistry, University of California, Berkeley, California 94720, USA.</style></auth-address><titles><title><style face="normal" font="default" size="100%">Strong CO2 binding in a water-stable, triazolate-bridged metal-organic framework functionalized with ethylenediamine</style></title><secondary-title><style face="normal" font="default" size="100%">J Am Chem Soc</style></secondary-title></titles><periodical><full-title><style face="normal" font="default" size="100%">J Am Chem Soc</style></full-title></periodical><pages><style face="normal" font="default" size="100%">8784-6</style></pages><volume><style face="normal" font="default" size="100%">131</style></volume><number><style face="normal" font="default" size="100%">25</style></number><edition><style face="normal" font="default" size="100%">2009/06/10</style></edition><dates><year><style face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style face="normal" font="default" size="100%">Jul 1</style></date></pub-dates></dates><isbn><style face="normal" font="default" size="100%">1520-5126 (Electronic)&#xD;0002-7863 (Linking)</style></isbn><accession-num><style face="normal" font="default" size="100%">19505094</style></accession-num><abstract><style face="normal" font="default" size="100%">Reaction of CuCl(2) x 2 H(2)O with 1,3,5-tris(1H-1,2,3-triazol-5-yl)benzene (H(3)BTTri) in DMF at 100 degrees C generates the metal-organic framework H(3)[(Cu(4)Cl)(3)(BTTri)(8)(DMF)(12)] x 7 DMF x 76 H(2)O (1-DMF). The sodalite-type structure of the framework consists of BTTri(3-)-linked [Cu(4)Cl](7+) square clusters in which each Cu(II) center has a terminal DMF ligand directed toward the interior of a large pore. The framework exhibits a high thermal stability of up to 270 degrees C, as well as exceptional chemical stability in air, boiling water, and acidic media. Following exchange of the guest solvent and bound DMF molecules for methanol to give 1-MeOH, complete desolvation of the framework at 180 degrees C generated H(3)[(Cu(4)Cl)(3)(BTTri)(8)] (1) with exposed Cu(II) sites on its surface. Following a previously reported protocol, ethylenediamine molecules were grafted onto these sites to afford 1-en, featuring terminal alkylamine groups. The N(2) adsorption isotherms indicate a reduction in the BET surface area from 1770 to 345 m(2)/g following grafting. The H(2) adsorption data at 77 K for 1 indicate a fully reversible uptake of 1.2 wt % at 1.2 bar, while the CO(2) isotherm at 195 K shows a maximal uptake of 90 wt % at 1 bar. Compared to 1, the alkylamine-functionalized framework 1-en exhibits a higher uptake of CO(2) at 298 K and pressures up to ca. 0.1 bar, as well as a higher CO(2)/N(2) selectivity at all measured pressures. Significantly, 1-en also exhibits an isosteric heat of CO(2) adsorption of 90 kJ/mol, which is much higher than the 21 kJ/mol observed for 1. This chemisorption interaction is the strongest reported to date for a metal-organic framework and points toward the potential utility of alkylamine-appended frameworks for the postcombustion capture of CO(2) from low-pressure flue gas streams.</style></abstract><notes><style face="normal" font="default" size="100%">Demessence, Aude&#xD;D&apos;Alessandro, Deanna M&#xD;Foo, Maw Lin&#xD;Long, Jeffrey R&#xD;eng&#xD;J Am Chem Soc. 2009 Jul 1;131(25):8784-6. doi: 10.1021/ja903411w.</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.ncbi.nlm.nih.gov/pubmed/19505094</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1021/ja903411w</style></electronic-resource-num></record></records></xml>